Congress trades in Teva Pharmaceutical Industries Limited (TEVA)
Healthcare · Drug Manufacturers - Specialty & Generic
3 members of Congress have disclosed 3 trades in Teva Pharmaceutical Industries Limited (TEVA) since 2016: 1 buy and 2 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Teva Pharmaceutical Industries Limited's industry.
- Trades disclosed
- 3
- Members trading
- 3
- Buys / sells
- 1 / 2
- Reported value
- $3K–$45K
Committee overlaps
Trades by members of a committee that oversees Teva Pharmaceutical Industries Limited's industry. An overlap is a fact about the trade, not evidence of wrongdoing.
Who traded TEVA
- Sen. Alan Armstrong (R-OK)1 buy · 0 sales10Jul 21, 2026
- Sen. Patty Murray (D-WA)0 buys · 1 sale01Jun 22, 2017
- Sen. Angus S. King, Jr. (I-ME)0 buys · 1 sale01Nov 10, 2016
All trades
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Teva Pharmaceutical Industries Limited TEVA
$1K–$15K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP - Jun 22, 2017$1K–$15K
Sen. Patty Murray (D-WA)
Sold (full) Teva Pharmaceutical Industries Limited TEVA
$1K–$15K · Traded Jun 15, 2017 · disclosed Jun 22, 2017 · Spouse
- Nov 10, 2016$1K–$15K
Sen. Angus S. King, Jr. (I-ME)
Sold (full) Teva Pharmaceutical Industries Limited TEVA
$1K–$15K · Traded Oct 19, 2016 · disclosed Nov 10, 2016 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.